Skip to main content
. 2018 Jul 12;7(14):e008078. doi: 10.1161/JAHA.117.008078

Table 1.

Characteristics of Study Participants Without and With Recurrent CHD Events in the REGARDS Cohort

Characteristic Total Mean±SD or n (%) No Recurrent CHD Event Mean±SD or n (%) Recurrent CHD Event Mean±SD or n (%) P Difference
N=3562 n=2981 n=581
Age, y 68.6±8.9 68.3±8.8 70.0±9.2 <0.001
Sex, male 2179 (61.2) 1772 (59.4) 407 (70.1) <0.001
Race, black 962 (27.0) 812 (27.2) 150 (25.8) 0.48
Education, did not graduate from high school 477 (13.4) 383 (12.9) 94 (16.2) 0.031
Household income <$20 000/y 686 (21.7) 557 (21.1) 129 (24.4) 0.092
Resident of stroke belta 2007 (56.3) 1692 (56.8) 315 (54.2) 0.26
Current smoker 527 (14.9) 434 (14.6) 93 (16.0) 0.38
Physically inactiveb 1276 (36.3) 1020 (34.6) 256 (44.9) <0.001
Total energy intake, kcal/day 1685±688 1684±687 1694±693 0.74
Body mass index, kg/m2 29.2±5.8 29.0±5.9 29.9±5.7 0.002
Waist circumference, cm 98.9±15.4 98.3±15.4 102.2±15.3 <0.001
Systolic blood pressure, mm Hg 129.2±16.9 128.6±16.7 132.3±17.9 <0.001
Hypertensionc 2506 (70.7) 2058 (69.3) 448 (77.6) <0.001
Dyslipidemiad 2716 (78.0) 2251 (77.2) 465 (81.9) 0.015
Diabetes mellituse 1030 (29.8) 786 (27.3) 244 (42.7) <0.001
Antihypertensive use 2298 (66.9) 1887 (65.9) 411 (72.2) 0.003
Statin use 2109 (59.2) 1759 (59.0) 350 (60.2) 0.58
Regular aspirin use 2512 (70.5) 2077 (69.7) 435 (75.0) 0.010
Oral antidiabetic use 759 (21.3) 582 (19.5) 177 (30.5) <0.001
Insulin use 334 (9.9) 245 (8.7) 89 (16.3) <0.001
PCS‐12 43.0±11.5 43.5±11.4 40.2±11.4 <0.001

CHD indicates coronary heart disease; PCS, Physical Component Summary; REGARDS, Reasons for Geographic and Racial Differences in Stroke study; SD, standard deviation.

a

Stroke belt consists of North Carolina, South Carolina, Georgia, Tennessee, Alabama, Mississippi, Arkansas, and Louisiana.

b

Physically active defined as ≥4 days of exercise (enough to work up a sweat) per week.

c

Hypertension defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg or self‐reported current use of medication to control blood pressure.

d

Dyslipidemia defined as total cholesterol ≥6.22 mmol/L (240 mg/dL) and/or low‐density lipoprotein cholesterol ≥4.14 mmol/L (160 mg/dL) and/or high‐density lipoprotein cholesterol ≤1.04 mmol/L (40 mg/dL) or self‐reported current use of medication to control cholesterol.

e

Diabetes mellitus defined as fasting glucose ≥6.99 mmol/L (126 mg/dL) and/or nonfasting glucose ≥11.10 mmol/L (200 mg/dL) or self‐reported current use of medication to control blood sugar.